Reconciling Quality by Design and Transdermal Product Development
Since my first exposure to the acronym ‘QbD’ more than ten years ago, I have been trying to understand exactly what QbD is and how I might incorporate its teachings into my twenty-odd years of experience developing transdermal systems. I feel I have made little progress since the...
Main Author: | Kenneth Miller |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/12/3/273 |
Similar Items
-
Design and Characterization of Spray-Dried Chitosan-Naltrexone Microspheres for Microneedle-Assisted Transdermal Delivery
by: Abayomi T. Ogunjimi, et al.
Published: (2020-05-01) -
Formulation design and development of matrix diffusion controlled transdermal drug delivery of glimepiride
by: Akram MR, et al.
Published: (2018-02-01) -
Microdermabrasion for transdermal drug delivery
by: Andrews, Samantha Nacole
Published: (2011) -
Myth or Reality—Transdermal Magnesium?
by: Uwe Gröber, et al.
Published: (2017-07-01) -
Transdermal patches: Design and current approaches to painless drug delivery
by: Al Hanbali Othman A., et al.
Published: (2019-06-01)